Get the Stockscreener App
1.295
2.78%
0.035
Bone Biologics Corp stock is traded at $1.295, with a volume of 12,832.
It is up +2.78% in the last 24 hours and up +6.15% over the past month.
Bone Biologics Corp a medical device company that is currently focused on bone regeneration in spinal fusion using the recombinant human protein known as NELL-1. NELL-1 in combination with DBM, demineralized bone matrix, is an osteopromotive recombinant protein that provides target specific control over bone regeneration. It is a clinical-stage entity. The production and marketing of its products and ongoing research and development activities are subject to extensive regulation by numerous governmental authorities in the United States.
See More
Previous Close:
$1.26
Open:
$1.29
24h Volume:
12,832
Relative Volume:
0.60
Market Cap:
$2.32M
Revenue:
-
Net Income/Loss:
$-3.11M
P/E Ratio:
-0.324
EPS:
-3.9975
Net Cash Flow:
$-2.69M
1W Performance:
+1.17%
1M Performance:
+6.15%
6M Performance:
-51.32%
1Y Performance:
-70.02%
1-Day Range:
$1.2899
$1.3122
1-Week Range:
$1.2201
$1.3122
52-Week Range:
$1.05
$6.75
Bone Biologics Corp Stock (BBLG) Company Profile
Name
Bone Biologics Corp
Sector
Industry
Phone
(781) 552-4452
Address
2 BURLINGTON WOODS DRIVE,, BURLINGTON
Compare BBLG vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BBLG
Bone Biologics Corp
|
1.295 | 2.26M | 0 | -3.11M | -2.69M | -3.9975 |
VRTX
Vertex Pharmaceuticals Inc
|
442.76 | 113.01B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
748.47 | 79.87B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
842.22 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
335.30 | 45.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
317.07 | 34.41B | 5.36B | 287.73M | 924.18M | 2.5229 |
Bone Biologics Corp Stock (BBLG) Latest News
Aug Weekly: What is Bone Biologics Corporation Equity Warrants revenue forecastExit Point & Fast Moving Market Watchlists - baoquankhu1.vn
Entry Recap: What is the Moat Score of Bone Biologics CorporationQuarterly Performance Summary & Consistent Return Strategy Ideas - baoquankhu1.vn
Biocon Announces U.S. Commercial Launch of Bosaya™ and Aukelso™, Denosumab Biosimilars - PharmiWeb.com
Market Structure, Emerging Trends, and Key Player Analysis in the Orthobiologics Devices and Equipment Sector - openPR.com
Earnings Update: Whats the profit margin of Aptiv PLC2026 Rallies & Capital Protection Trading Alerts - baoquankhu1.vn
Exit Recap: Is Bone Biologics Corporation a strong candidate for buy and holdEarnings Risk Summary & Low Risk Entry Point Guides - baoquankhu1.vn
Global Drivers Analysis: Factors Behind the Rapid Evolution of the Demineralized Bone Matrix Market - openPR.com
Stock List: Research Stocks from Around the World - GuruFocus
Aug PostEarnings: Is INNOVATE Corp a top pick in the sector2026 Valuation Update & Weekly High Conviction Ideas - baoquankhu1.vn
Competitive Analysis: Leading Companies and New Entrants in the Bone Graft Fixation System Market - openPR.com
Gains Report: What is the implied volatility of Bone Biologics Corporation Equity Warrant2026 Selloffs & Capital Protection Trade Alerts - baoquankhu1.vn
Aug Sentiment: Is Bone Biologics Corporation stock a good pick for beginners2026 Analyst Calls & Weekly Top Performers Watchlists - baoquankhu1.vn
Downgrade Watch: Is BCPC likely to announce a buyback2026 Key Highlights & Daily Profit Maximizing Tips - baoquankhu1.vn
If You Invested $1,000 in Bone Biologics Corp (BBLG) - Stock Titan
BBLG Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Market Leaders: Can Bone Biologics Corporation Equity Warrant sustain its profitability2026 Snapshot & Weekly Stock Performance Updates - baoquankhu1.vn
Bone Biologics Corporation Announces $1 Million At-the-Market Offering of Common Stock Through H.C. Wainwright & Co - Minichart
Bone Biologics launches $1.06 million at-the-market offering on Nasdaq - Investing.com
Bone Biologics launches $1.064M at-the-market equity program via H.C. Wainwright - TradingView
Bone Biologics (NASDAQ: BBLG) adds $1.064M at-the-market stock capacity - Stock Titan
Bone Biologics (NASDAQ: BBLG) launches $1.06M ATM sale with Wainwright - Stock Titan
BBLG PE Ratio & Valuation, Is BBLG Overvalued - Intellectia AI
Aug Movers: What is Bone Biologics Corporation Equity Warrant s revenue forecastGlobal Markets & Entry Point Strategy Guides - baoquankhu1.vn
Trading Action: Does NVFY stock benefit from AI growthPortfolio Value Summary & Free High Accuracy Swing Entry Alerts - baoquankhu1.vn
Treasury Yields: Is InMode Ltd a top pick in the sector2025 Top Decliners & AI Based Buy/Sell Signal Reports - baoquankhu1.vn
Surprises Report: Is Bone Biologics Corporation Equity Warrant still a buy after recent gainsJuly 2025 Outlook & Advanced Swing Trade Entry Alerts - baoquankhu1.vn
Bone Biologics FY2026 EPS Forecast Reduced by Zacks Research - Defense World
Aug Technicals: What is Bone Biologics Corporations valuation compared to sectorJuly 2025 Catalysts & Trade Opportunity Analysis Reports - baoquankhu1.vn
Brokers Issue Forecasts for Bone Biologics Q1 Earnings - Defense World
Aug Summary: Will IBEX outperform during market rallies2025 Geopolitical Influence & Reliable Price Action Trade Plans - baoquankhu1.vn
BBLG Technical Analysis & Stock Price Forecast - Intellectia AI
AI Investing InsightsOfficial HomepageIntellectia AI™ - Intellectia AI
BBLG Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
BBLG Earnings History & Surprises | EPS & Revenue Results | BONE BIOLOGICS CORP (NASDAQ:BBLG) - ChartMill
getLinesFromResByArray error: size == 0 What sentiment indicators say about Bone Biologics Corporation Equity Warrant stockIndex Update & Reliable Intraday Trade Alerts - mfd.ru
Bone Biologics (NASDAQ: BBLG) flags going concern and limited cash runway - Stock Titan
Bone Biologics 10-K: Operating loss $3.23M, net loss $3.11M; EPS impact noted - TradingView
New fibroblast cell therapy patent targets osteoporosis - Stock Titan
Bone Marrow Aspirate Concentrates Market: Competitive - openPR.com
BBLG Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
Stop Loss: Is WULF stock a value trapDip Buying & Stepwise Trade Signal Guides - baoquankhu1.vn
BBLGBone Biologics Corp Latest Stock News & Market Updates - Stock Titan
What is Bone Biologics Corporation’s valuation compared to sectorStock Surge & Verified Momentum Stock Ideas - mfd.ru
IPO Launch: What is Bone Biologics Corporation Equity Warrants market positionJuly 2025 PostEarnings & Low Risk Entry Point Guides - baoquankhu1.vn
Bone Biologics Corp expected to post a loss of 34 cents a shareEarnings Preview - TradingView
Bone Biologics (BBLG) to Release Quarterly Earnings on Wednesday - Defense World
Can Bone Biologics Corporation stock deliver surprise earnings beatWeekly Volume Report & Free Risk Controlled Daily Trade Plans - mfd.ru
Stock Market Recap: How does Universal Corporation compare to its peersInsider Buying & Weekly Momentum Stock Picks - baoquankhu1.vn
NUWE PE Ratio & Valuation, Is NUWE Overvalued - Intellectia AI
Is Bone Biologics Corporation a stock for growth or value investorsWeekly Stock Recap & Growth Oriented Trade Recommendations - mfd.ru
Bone Biologics Corp Stock (BBLG) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.68%
0.34%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):